Phiten USA Revenue and Competitors
Estimated Revenue & Valuation
- Phiten USA's estimated annual revenue is currently $4.6M per year.
- Phiten USA's estimated revenue per employee is $158,900
Employee Data
- Phiten USA has 29 Employees.
- Phiten USA grew their employee count by 12% last year.
Phiten USA's People
Name | Title | Email/Phone |
---|---|---|
1 | National Sales Manager | Reveal Email/Phone |
Phiten USA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.1M | 50 | 2% | N/A | N/A |
#2 | $30.6M | 135 | 4% | N/A | N/A |
#3 | $5980M | 12975 | 6% | N/A | N/A |
#4 | $41M | 164 | 9% | N/A | N/A |
#5 | $755.7M | 2378 | 10% | N/A | N/A |
#6 | $3.7M | 23 | -4% | N/A | N/A |
#7 | $3.8M | 24 | 0% | N/A | N/A |
#8 | $0.1M | 1 | 0% | N/A | N/A |
#9 | $165.2M | 573 | 0% | $3M | N/A |
#10 | $8.7M | 48 | 0% | N/A | N/A |
What Is Phiten USA?
Phiten® is the unprecedented forerunner and pioneer of AQUA-METAL™ materials and the advancement of metal-infused technology. Founded in 1983 in Kyoto, Japan, Phiten has been inspiring individuals to live and strive for a balanced lifestyle with groundbreaking technology and design applied to active apparel, support products, footwear, and accessories. Holding over 100 patents worldwide and with over 30 distributors across the globe, Phiten has established itself as a symbol of sports, health, and wellness. Phiten is a licensed partner of the NBA® and the NHL®, and the Authentic Collection Licensed Partner of MLB®, holding the rights as the Official Compression Sleeve of Major League Baseball®. Phiten products are available at professional sports stadiums, sporting goods retailers, pharmacies, and chiropractic clinics across the nation.
keywords:N/AN/A
Total Funding
29
Number of Employees
$4.6M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3M | 29 | -6% | N/A |
#2 | N/A | 29 | 45% | N/A |
#3 | $4.3M | 29 | -38% | N/A |
#4 | $5.9M | 30 | 7% | N/A |
#5 | N/A | 30 | 114% | N/A |